第43回高桑榮松奨学基金奨励賞 久田 諒先生
第43回高桑榮松奨学基金奨励賞 久田 諒先生
Hirahara L, Kirino Y, Soejima Y, Iizuka Y, Yoshimi R, Fujieda Y, Atsumi T, Tono T, Kobayashi D, Meguro A, Takeuchi M, Sakamaki K, Takeno M, Mizuki N, Nakajima H Association of high disease activity and serum IL-6 levels with the incidence of inflammatory major organ events in Behçet disease: a prospective registry study Frontiers in Immunology, in press.
IF：7.3
Nashimoto S, Miyamae M, Higuchi I, Kono M, Tada M, Atsumi T, Sugawara M, Takekuma Y.
Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report.
Case Reports in Nephrology and Dialysis. in press
IF=0.7
Chighizola CB, Willis R, Maioli G, Sciascia S, Andreoli L , Amengual O, Radin M , Gerosa M, Atsumi T, de Jesus G , Trespidi L , Branch DW , Caporali R, Andrade D, Roubey R , Petri M , Bertolaccini ML.
Deciphering the clinical significance of longitudinal antiphospholipid antibody titers.
Autoimmunity Reviews, in press
IF: 17.39
Kato M, Kiuchi Y, Atsumi T, Furukawa S.
Vertebral involvement detected by tomosynthesis in SAPHO syndrome.
Rheumatology (Oxford). in press
IF=5.5
第10回JCRベーシックリサーチカンファレンス ポスター賞 工藤 友喜さん
Aika Miya, Akinobu Nakamura, Hiroshi Nomoto, Hiraku Kameda, Tatsuya Atsumi Positive association between the proinsulin-to-C-peptide ratio and prolonged hyperglycemic time in type 2 diabetes Endocrine Journal, in press.
IF=2.0
Sugawara M, Osanami A, Asai Y, Ogawa Y, Nagahata K, Nakamura H, Suzuki C, Kanda M, Takahashi H.
Successful treatment of ANCA-associated glomerulonephritis following pulmonary alveolar proteinosis by rituximab and avacopan.
Rheumatology, in press.
IF: 5.5
Iesaka H, Kameda H, Miya A, Nomoto H, Cho KY, Nakamura A, Abe T, Shinohara N, Atsumi T Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and
ipilimumab: A case report
Medicine, in press
IF: 1.6
Izumihara R, Nomoto H*, Kito K, Yamauchi Y, Omori K, Shibayama Y, Yanagiya S, Miya A, Kameda H, Cho KY, Nagai S, Sakuma I, Nakamura A, Atsumi T.
Switching from conventional fibrates to pemafibrate has beneficial effects on the renal function of diabetic subjects with chronic kidney disease.
Diabetes Metab J, in press.
IF: 5.9, 5-Y IF: 5.4